NOLUMA_1170x120_10-11-19

Walgreens Boots Alliance

Fred’s adopts ‘poison pill’ plan

Fred’s adopts ‘poison pill’ plan

MEMPHIS, Tenn. — Fred’s Inc. has adopted a shareholder rights plan, also known as a “poison pill,” after a hedge fund recently became the company’s single largest shareholder. Fred’s said Tuesday its board instituted the shareholder rights plan after observing “unusual and substantial activity in the company’s shares.” The discount and pharmacy retailer noted that

Rite Aid sales, earnings decline in Q3

Rite Aid sales, earnings decline in Q3

CAMP HILL, Pa. — Rite Aid Corp. said slim reimbursement rates, new generic drugs and the ongoing antitrust talks for the merger with Walgreens Boots Alliance (WBA) squeezed sales and earnings for its fiscal 2017 third quarter. Rite Aid said Thursday that for the third quarter ended Nov. 26, sales dipped 0.8% to $8.09 billion

WBA beats Wall Street’s 4Q, full-year earnings forecast

WBA beats Wall Street’s 4Q, full-year earnings forecast

DEERFIELD, Ill. — As talks roll on to gain regulatory clearance for its acquisition of Rite Aid Corp., Walgreens Boots Alliance (WBA) posted adjusted earnings for its fiscal 2016 fourth quarter and full year that topped Wall Street’s estimates. WBA said Thursday that GAAP net earnings attributable to Walgreens Boots Alliance totaled $1.03 billion, or

WBA ups store sell-off estimate for Rite Aid deal

WBA ups store sell-off estimate for Rite Aid deal

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) said it’s working on store divestiture scenarios with the Federal Trade Commission to gain clearance for its $17.2 billion deal to acquire Rite Aid Corp. WBA said Thursday that it and Rite Aid “remain actively engaged” in talks with the FTC as the regulator reviews the acquisition, which

Walgreens Boots Alliance posts 3Q gains

Walgreens Boots Alliance posts 3Q gains

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) saw sales and adjusted net earnings rise in its fiscal 2016 third quarter, with adjusted earnings per share exceeding Wall Street’s consensus forecast. WBA said Wednesday that its pending acquisition of Rite Aid Corp. remains on track for completion in the second half of this year, and it

Rivals make each other better

Rivals make each other better

Only days — or weeks — may remain until Walgreens Boots Alliance’s long-delayed acquisition of Rite Aid gets the go-ahead from the Federal Trade Commission. If and when that clearance comes, Rite Aid will officially become part of WBA, and the competition between the Walgreens and CVS Pharmacy drug chains will finally take form so

Rite Aid turns in net loss for first quarter

Rite Aid turns in net loss for first quarter

CAMP HILL, Pa. — Rite Aid Corp. cited pressure in pharmacy reimbursement as it reported a net loss and fell short of Wall Street’s earnings forecast for its fiscal 2017 first quarter. Meanwhile, overall retail sales and same-store sales edged up for the quarter, and the EnvisionRx pharmacy benefit management business, acquired about a year

Pessina: U.S. market WBA’s ‘greatest opportunity’

Pessina: U.S. market WBA’s ‘greatest opportunity’

NEW YORK — Walgreens Boots Alliance’s deal to acquire Rite Aid and partnership with Valeant Pharmaceuticals will build on WBA’s strong start in its first full year as a unified company, executive vice chairman and CEO Stefano Pessina said here at the annual shareholders meeting. “I am happy to say that we are on track

WBA begins fiscal 2016 on strong note

WBA begins fiscal 2016 on strong note

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) topped Wall Street’s earnings projections for its fiscal 2016 first quarter. WBA said Thursday that for the first quarter ended Nov. 30, 2015, adjusted net earnings attributable to Walgreens Boots Alliance were $1.13 billion, or $1.03 per diluted share, compared with $749 million, or 78 cents per diluted

1 4 5 6